The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug Provigil ...

Mark Sheehan, who played lead guitar for the alt-pop group The Script, died Friday after a brief illness. The band announced the news on Facebook, writing, “Much loved husband, father, brother, band ...

How to run script in Microsoft 365 Excel for the web Your email has been sent The ability to automate tasks in Excel for the web has been a long wait—but it’s ...

We all love the natural salesperson. They seem to be able to book meetings effortlessly. But of course, getting appointments is not the same as closing. To reliably close, salespeople must identify ...

A new script allows you to install Windows 11 on devices with incompatible hardware, such as missing TPM 2.0, incompatible CPUs, or the lack of Secure Boot. Even better, the script also works on ...

Cephalon induced Teva to stop generic from 2005 to 2011 Case is fourth in series against pay-for-delay drug deals Cephalon now a subsidiary of Teva BRUSSELS, Nov 26 (Reuters) - The European Commission ...

Here are some upcoming events of interest to the intellectual property law community. Unless otherwise noted, all times are local, and court appearances are virtual due to the COVID-19 pandemic.

Teva Pharmaceutical Industries Ltd and its Cephalon unit were fined €60.5 million by the European Union for a pact that delayed sales of a cheaper version of a sleep-disorder drug. Teva received cash ...

"Teva’s and Cephalon’s pay-for-delay agreement harmed patients and national health systems, depriving them of more affordable medicines," said EU competition commissioner, Margrethe Vestager. Brussels ...

BRUSSELS, Nov 26 (Reuters) - The European Commission has fined pharmaceutical companies Teva and Cephalon 60.5 million euros ($72.0 million) for agreeing to delay a cheaper generic version of Cephalon ...

BRUSSELS (Reuters) - The European Commission has fined pharmaceutical company Teva and its now subsidiary Cephalon 60.5 million euros (£54 million) for agreeing to delay a cheaper generic version of ...